NCT02022046View on ClinicalTrials.gov

Methylation Biosignature in Childhood Chronic Kidney Disease

CompletedOBSERVATIONAL
Enrollment

69

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

November 30, 2016

Study Completion Date

December 31, 2016

Conditions
Chronic Kidney DiseaseCardiovascular Disease
Interventions
OTHER

Methylation biosignature

Methylation biosignature, CKD staging, assessment of cardiovascular function, and traditional/uremia-related risk factors will be performed.

Trial Locations (1)

833

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT02022046 - Methylation Biosignature in Childhood Chronic Kidney Disease | Biotech Hunter | Biotech Hunter